Sergio Quezada

Sergio Quezada is an accomplished professional with a strong background in Biochemistry and Molecular Biology. He pursued his Bachelor of Science degree at Pontificia Universidad Católica de Chile. With a wealth of experience in the field of Cancer Immunology and Immunotherapy, Sergio has held key positions in various prestigious organizations. Currently, he serves as the Chief Scientific Officer at Achilles Therapeutics Limited, a role that showcases his leadership and expertise in the scientific domain. Prior to his current position, Sergio was a Co-Founder at Achilles Therapeutics Limited, demonstrating his entrepreneurial spirit and strategic mindset in establishing successful ventures. His academic journey includes holding the position of Professor of Cancer Immunology and Immunotherapy at UCL Cancer Institute, where he contributed significantly to the research and academic community. Additionally, Sergio has experience as a Research Associate at Memorial Sloan-Kettering Cancer Center and as a PhD student at Dartmouth College, reflecting his dedication to advancing knowledge and making valuable contributions to the field of Cancer Immunology.